KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Income (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Operating Income for 11 consecutive years, with $153.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income rose 22.25% year-over-year to $153.3 million, compared with a TTM value of $534.9 million through Dec 2025, up 19.71%, and an annual FY2025 reading of $534.9 million, up 19.71% over the prior year.
  • Operating Income was $153.3 million for Q4 2025 at Medpace Holdings, up from $141.8 million in the prior quarter.
  • Across five years, Operating Income topped out at $153.3 million in Q4 2025 and bottomed at $42.4 million in Q2 2021.
  • Average Operating Income over 5 years is $89.8 million, with a median of $85.6 million recorded in 2023.
  • The sharpest move saw Operating Income dropped 0.24% in 2021, then surged 44.89% in 2022.
  • Year by year, Operating Income stood at $54.9 million in 2021, then skyrocketed by 39.33% to $76.4 million in 2022, then rose by 14.25% to $87.3 million in 2023, then soared by 43.58% to $125.4 million in 2024, then grew by 22.25% to $153.3 million in 2025.
  • Business Quant data shows Operating Income for MEDP at $153.3 million in Q4 2025, $141.8 million in Q3 2025, and $126.3 million in Q2 2025.